A Study of the Safety and Efficacy of Microplasmin to Induce a Posterior Vitreous Detachment (MIVI III)

Completed · Phase 2 · Has a placebo group

Conditions studied: Vitrectomy

In brief

A multicenter study to compare multiple doses of intravitreal microplasmin in patients undergoing surgical vitrectomy.

Key facts

Study ID
NCT00412958
Run by
ThromboGenics
People needed
125
Starts
2006-12-01
Expected to finish
2008-10-01
Last updated by the study team
2014-12-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.